Table 1.
Patient | Number of CCR9+ cells (mean ± SE) |
Number of CD14+ cells (mean ± SE) |
Number of CCR9+/CD14+ cells (mean ± SE) |
---|---|---|---|
Rheumatoid | |||
1 (n = 92) | 25 ±10 | 36 ± 9 | 25 ± 10 |
2 (n = 91) | 59 ± 23 | 45 ± 25 | 43 ± 24 |
3 (n = 137) | 64 ± 20 | 64 ± 20 | 51 ±12 |
4 (n = 136) | 60 ± 10 | 60 ± 13 | 59 ± 12 |
5 (n = 173) | 65 ± 23 | 80 ± 35 | 62 ± 24 |
6 (n = 166) | 106 ± 9 | 135 ± 11 | 104 ± 9 |
Overall mean ± SE | 63 ± 10 | 70 ± 14 | 57 ± 11 |
Non-rheumatoid | |||
1 (n = 76) | 38 ± 12 | 1 ± 1 | 1 ± 1 |
2 (n = 77) | 5 ± 5 | 4 ± 3 | 3 ± 3 |
3 (n = 70) | 9 ± 4 | 4 ± 6 | 4 ± 6 |
4 (n = 47) | 5 ± 1 | 5 ± 2 | 4 ± 3 |
5 (n = 75) | 5 ± 3 | 11 ± 4 | 5 ± 4 |
6 (n = 75) | 10 ± 3 | 10 ± 2 | 7 ± 2 |
Overall mean ± SE | 12 ± 5 | 6 ± 2 | 4 ± 1 |
The data are mean numbers of positive cells (± standard error) per field of view; n = mean number of total cells sampled per field of view as assessed by counting the numbers of nuclei stained by DAPI.